feed,title,long_url,short_url
Benzinga,"MetroCity Bankshares, Inc. Reports Earnings For Fourth Quarter And Year Ended 2020",https://www.benzinga.com/pressreleases/21/01/n19279428/metrocity-bankshares-inc-reports-earnings-for-fourth-quarter-and-year-ended-2020,https://j.mp/39QlFok
Benzinga,"Welcoming Gina Robertson, new VP of Client Services, to Ansafone Contact Centers' Leadership Team",https://www.benzinga.com/pressreleases/21/01/n19279402/welcoming-gina-robertson-new-vp-of-client-services-to-ansafone-contact-centers-leadership-team,https://j.mp/396sUZZ
Benzinga,InventHelp Inventor Develops Environmentally-Friendly Design for Caskets (LVT-359),https://www.benzinga.com/pressreleases/21/01/n19279391/inventhelp-inventor-develops-environmentally-friendly-design-for-caskets-lvt-359,https://j.mp/398vEGj
Benzinga,"Worldwide Industry for Insulin Delivery Systems to 2025 - Featuring Sanofi, Tandem Diabetes Care and Ypsomed Holding Among Others",https://www.benzinga.com/pressreleases/21/01/n19279390/worldwide-industry-for-insulin-delivery-systems-to-2025-featuring-sanofi-tandem-diabetes-care-and-,https://j.mp/2LYT8oH
Benzinga,IIROC Trading Resumption - TES,https://www.benzinga.com/pressreleases/21/01/n19279388/iiroc-trading-resumption-tes,https://j.mp/394SnDg
Benzinga,BirchBioMed Inc. Announces Positive Topline Data from Phase 2 Study of FS2 for Treatment of Keloid Scars,https://www.benzinga.com/pressreleases/21/01/n19279385/birchbiomed-inc-announces-positive-topline-data-from-phase-2-study-of-fs2-for-treatment-of-keloid-,https://j.mp/398pGFF
Benzinga,BirchBioMed Inc. Announces Positive Topline Data from Phase 2 Study of FS2 for Treatment of Keloid Scars,https://www.benzinga.com/pressreleases/21/01/n19279383/birchbiomed-inc-announces-positive-topline-data-from-phase-2-study-of-fs2-for-treatment-of-keloid-,https://j.mp/3oaIDeQ
